Gallox Semiconductors, Inc.
Gallox produces ultrawide bandgap gallium oxide (Ga203) semiconductor devices that eliminate that inefficiency, enable more powerful electronics circuitry, and reduce a system’s size, weight and engineering complexity.
EchoICs, Inc.
EchoICs is developing a reconfigurable radio platform with extended battery life, enhanced dynamic range, reduced size and system cost that allows improvement in output power, system efficiency, and receiver linearity.
Vescor Therapeutics Inc.
Vescor Therapeutics Inc., is an immuno-oncology company that is developing new therapies that modulate endoplasmic reticulum (ER) stress response pathways in the tumor microenvironment. Chronic activation of this stress response is linked to poor outcomes in multiple cancers, such as ovarian cancer, triple-negative breast cancer, pancreatic adenocarcinoma and glioblastoma. The company was founded based on intellectual property generated from Weill Cornell Medicine and is developing small molecule therapeutics that inhibit the enzyme IRE1α.
Anova Biomedical
Anova Biomedical is developing synthetic bioresorbable grafts to enable long-term, incident-free hemodialysis. The technology originated in Professor Yadong Wang’s lab and is spun out thanks to the Ignite Fellow for New Venture program, a startup accelerator from Cornell.
ExoPower, Inc
ExoPower is revolutionizing charging for mobile robots by solving the battery charging issue through an in-motion capacitive wireless solution.
Graphenode, Inc.
Leveraging the latest in nanotechnology, Graphenode’s patent-pending SiGraph™ anode additive encases silicon in a graphene nanoweb to harness silicon’s superior energy density.
GIANT Biosystems, Inc.
GIANT BioSystems, founded by a team of elite scientists from leading institutions such as Cornell, Caltech, Harvard, UCLA, and MIT (Dr. Ehsan Shirzaei Sani, CEO/Co-Founder; Dr. Morteza Azizi, CTO/Co-Founder; Canran Wang, COO/Co-Founder; and Samuel Solomon, CSO/Director of AI), is pioneering an AI/ML-assisted microfluidics-based platform for high-throughput antimicrobial susceptibility testing (AST) and drug/antibiotic discovery. GIANT’s patented microfluidics chip facilitates the simultaneous screening of over 50 antibiotics in just 3-5 hours with exceptional precision. The GIANT platform is cost-effective, compact, highly precise, and user-friendly, requiring no complex training.
SACYL Pharmaceuticals
Sacyl Pharmaceuticals (SACYL) aims to develop potent soluble adenylyl cyclase (sAC) inhibitors into first-in-class systemic, non-hormonal, on-demand contraceptives for men and women with the goal to significantly contribute to increased use of modern contraceptives among couples to reduce unintended pregnancies, improving families’ health and well-being globally.
Carbon to Stone, Inc
Carbon mineralization is a natural process. Carbon to Stone perfected a reactive crystallization process that matches the scale and speed of climate crisis demands.
